FDA OTHER_CORRESPONDENCE - ImprimisRx NJ - June 19, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This OTHER CORRESPONDENCE record concerns ImprimisRx NJ, with an inspection on June 19, 2017, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: ImprimisRx NJ
Inspection Date: June 19, 2017
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Barbara Wilimczyk-Macri (Senior Compliance Officer)
Diana Amador-Toro (District Director)
Craig W. Swanson (Deputy District Director)
Pramod K. Sharma

Open in Dashboard

ID · cac77b51-1b4c-4dd9-9e34-f7f958d1087e

Violation Codes9

21 CFR 211.113(b)FD&C Act 503A(b)(1)(A)(i)FD&C Act 501(a)(2)(B)FD&C Act 503AFD&C Act 301(k)FD&C Act 505FD&C Act 501(a)(2)(A)FD&C Act 502(f)(1)21 U.S.C. 353a

Full citation text and observation details available on the Dashboard.